Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$142M |
| 2 |
Procter & Gamble
PG
|
+$74.5M |
| 3 |
PepsiCo
PEP
|
+$60.9M |
| 4 |
Pinduoduo
PDD
|
+$58.5M |
| 5 |
Johnson & Johnson
JNJ
|
+$56.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$565M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$337M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$335M |
| 4 |
Walmart Inc
WMT
|
+$314M |
| 5 |
Danaher
DHR
|
+$214M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 27.98% |
| 2 | Consumer Discretionary | 17.74% |
| 3 | Healthcare | 17.12% |
| 4 | Industrials | 3.53% |
| 5 | Financials | 3.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Rio Tinto
RIO
$164B
| $2.53M | 0.01% |
37,842
+7,065
| +23% | +$457K |
|
427
Pediatrix Medical
MD
$2.2B
| $2.52M | 0.01% |
92,734
+13,624
| +17% | +$365K |
|
428
Booking.com
BKNG
$161B
| $2.52M | 0.01% |
26,250
-5,300
| -17% | -$502K |
|
429
Ingles Markets
IMKTA
$1.67B
| $2.48M | 0.01% |
28,730
-4,910
| -15% | -$375K |
|
430
MGP Ingredients
MGPI
$375M
| $2.47M | 0.01% |
29,035
-9,596
| -25% | -$723K |
|
|
OCFT
431
DELISTED
OneConnect Financial Technology
OCFT
| $2.47M | 0.01% |
99,821
+18,710
| +23% | +$554K |
|
432
Usana Health Sciences
USNA
$286M
| $2.46M | 0.01% |
24,279
-10,756
| -31% | -$1.07M |
|
433
LPL Financial
LPLA
$28.6B
| $2.45M | 0.01% |
15,288
-17,303
| -53% | -$2.86M |
|
434
FIGS
FIGS
$2.37B
| $2.42M | 0.01% |
87,788
-32,925
| -27% | -$1.08M |
|
435
Astrana Health
ASTH
$1.77B
| $2.39M | 0.01% |
32,483
-16,041
| -33% | -$1.32M |
|
436
Outset Medical
OM
$90.8M
| $2.38M | 0.01% |
3,437
+501
| +17% | +$371K |
|
437
Exelon
EXC
$47B
| $2.37M | 0.01% |
+57,555
| New | +$2.17M |
|
438
Weis Markets
WMK
$1.86B
| $2.36M | 0.01% |
35,802
-10,206
| -22% | -$619K |
|
439
Equitable Holdings
EQH
$14.1B
| $2.33M | 0.01% |
70,950
-94,285
| -57% | -$3.09M |
|
440
Qiagen
QGEN
$8.72B
| $2.31M | 0.01% |
39,210
-51
| -0.1% | -$2.92K |
|
441
Southern Company
SO
$107B
| $2.28M | 0.01% |
+33,282
| New | +$2.12M |
|
442
American Electric Power
AEP
$68.4B
| $2.28M | 0.01% |
+25,585
| New | +$2.16M |
|
443
American Well
AMWL
$230M
| $2.27M | 0.01% |
18,798
-2,321
| -11% | -$354K |
|
444
Ovintiv
OVV
$16.4B
| $2.27M | 0.01% |
+67,333
| New | +$2.4M |
|
445
Spectrum Brands
SPB
$2.07B
| $2.27M | 0.01% |
22,290
-18,943
| -46% | -$1.86M |
|
446
Broadridge
BR
$19B
| $2.25M | 0.01% |
12,315
+10,772
| +698% | +$1.89M |
|
447
Universal Display
OLED
$4.19B
| $2.25M | 0.01% |
+13,632
| New | +$2.25M |
|
448
National Beverage
FIZZ
$3.01B
| $2.25M | 0.01% |
49,578
-115,830
| -70% | -$6.3M |
|
|
AXNX
449
DELISTED
Axonics, Inc. Common Stock
AXNX
| $2.24M | 0.01% |
39,980
-3,124
| -7% | -$191K |
|
450
Fulgent Genetics
FLGT
$527M
| $2.21M | 0.01% |
22,009
-5,761
| -21% | -$506K |
|
Similar funds
Ray Dalio's Q4 2021 Portfolio in Review
As of Q4 2021, Ray Dalio held 820 positions worth $17.2B, down 5.8% from $18.3B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Ray Dalio withdrew a net $1.89B in Q4 2021, closing 89 positions and reducing 292 holdings. Its most notable exit was Ecolab, an estimated $14.2M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Ray Dalio opened a new position in RTX Corp worth $16M.
- Ray Dalio's largest Q4 2021 buy was RTX Corp: 186,232 shares worth $16M.
- Ray Dalio added most to Alibaba in Q4 2021, an estimated $142M increase.
- Ray Dalio's biggest Q4 2021 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $565M.
- Ray Dalio fully exited Ecolab in Q4 2021, selling an estimated $14.2M.
- Ray Dalio's ten largest holdings make up 36% of its $17.2B portfolio in Q4 2021.
- Ray Dalio opened 137 new positions and closed 89 in Q4 2021.
- Ray Dalio's portfolio value fell 5.8% quarter-over-quarter to $17.2B.
Based on Bridgewater Associates's 13F filing for Q4 2021, filed 14 Feb 2022.